We have received confirmation that our final report in the ACTTiVAte project has been accepted. This marks the end of this stage of works on BubbleFoot – a device for diabetic foot carboxytherapy with the use of micro- and nanobubble technology (MNB). The support we received from the ACTTiVAte project was manifold. In addition to the financial grant, it included training, workshops and mentoring, the value of which is invaluable to us.
We intend to work on and refine the product we built the prototype of. We are also looking for an investor who would wish to co-finance its commercialization. We see a place on the market for four technologically related device groups, targeted at slightly different recipients – from individual users, through wellness & SPA rooms, physiotherapeutic practices, to hospitals and outpatient clinics. The benefit for patients who, thanks to using BubbleFoot, can avoid painful ailments or even amputations, would be huge.
Once again – thank you ACTTiVAte!